Simulations Plus Future Growth

Future criteria checks 4/6

Simulations Plus is forecast to grow earnings and revenue by 29.5% and 13.8% per annum respectively while EPS is expected to grow by 27.5% per annum.

Key information

29.5%

Earnings growth rate

27.5%

EPS growth rate

Healthcare Services earnings growth	29.1%
Revenue growth rate	13.8%
Future return on equity	n/a
Analyst coverage	Low
Last updated	04 Apr 2024

Recent future growth updates

Recent updates

Why We're Not Concerned About Simulations Plus, Inc.'s (NASDAQ:SLP) Share Price

Mar 29

Capital Allocation Trends At Simulations Plus (NASDAQ:SLP) Aren't Ideal

Feb 09

Simulations Plus: Questionable Whether It Will Benefit Or Be Hurt By Generative AI

Feb 01

We Like Simulations Plus' (NASDAQ:SLP) Earnings For More Than Just Statutory Profit

Jan 12

Capital Allocation Trends At Simulations Plus (NASDAQ:SLP) Aren't Ideal

Nov 06

Estimating The Intrinsic Value Of Simulations Plus, Inc. (NASDAQ:SLP)

Sep 06

Here's What's Concerning About Simulations Plus' (NASDAQ:SLP) Returns On Capital

Jun 28

Some Investors May Be Worried About Simulations Plus' (NASDAQ:SLP) Returns On Capital

Feb 10

With EPS Growth And More, Simulations Plus (NASDAQ:SLP) Makes An Interesting Case

Nov 23

A Look At The Intrinsic Value Of Simulations Plus, Inc. (NASDAQ:SLP)

Oct 21

Here's What's Concerning About Simulations Plus' (NASDAQ:SLP) Returns On Capital

Sep 19

Simulations Plus goes ex-dividend tomorrow

Jul 21

Simulations Plus Q3 2022 Earnings Preview

Jul 05

Simulations Plus (NASDAQ:SLP) Might Be Having Difficulty Using Its Capital Effectively

Jun 08

Estimating The Fair Value Of Simulations Plus, Inc. (NASDAQ:SLP)

Mar 02

Simulations Plus: Software For The Pharma Industry, Significant Upside Potential

Mar 01

This Is Why We Think Simulations Plus, Inc.'s (NASDAQ:SLP) CEO Might Get A Pay Rise Approved By Shareholders

Feb 05

Be Wary Of Simulations Plus (NASDAQ:SLP) And Its Returns On Capital

Jan 18

Are Simulations Plus, Inc. (NASDAQ:SLP) Investors Paying Above The Intrinsic Value?

Nov 24

The Returns On Capital At Simulations Plus (NASDAQ:SLP) Don't Inspire Confidence

Oct 11

Calculating The Intrinsic Value Of Simulations Plus, Inc. (NASDAQ:SLP)

Aug 17

Earnings and Revenue Growth Forecasts

NasdaqGS:SLP - Analysts future estimates and past financials data (USD Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
8/31/2026	90	N/A	15	N/A	1
8/31/2025	76	17	12	N/A	2
8/31/2024	68	13	10	N/A	3
2/29/2024	65	11	13	18	N/A
11/30/2023	62	11	13	17	N/A
8/31/2023	60	10	18	22	N/A
5/31/2023	56	10	22	27	N/A
2/28/2023	54	10	18	22	N/A
11/30/2022	53	11	15	19	N/A
8/31/2022	54	12	14	18	N/A
5/31/2022	52	12	14	18	N/A
2/28/2022	50	12	14	19	N/A
11/30/2021	48	10	12	17	N/A
8/31/2021	46	10	15	19	N/A
5/31/2021	46	12	12	16	N/A
2/28/2021	46	11	10	14	N/A
11/30/2020	43	10	11	14	N/A
8/31/2020	42	9	8	11	N/A
5/31/2020	40	9	6	9	N/A
2/29/2020	38	9	8	10	N/A
11/30/2019	36	9	10	12	N/A
8/31/2019	34	9	10	12	N/A
5/31/2019	33	8	10	12	N/A
2/28/2019	31	7	9	11	N/A
11/30/2018	30	9	7	9	N/A
8/31/2018	30	9	7	9	N/A
5/31/2018	29	9	6	8	N/A
2/28/2018	27	8	7	9	N/A
11/30/2017	26	6	N/A	8	N/A
8/31/2017	24	6	N/A	7	N/A
5/31/2017	22	5	N/A	7	N/A
2/28/2017	21	5	N/A	6	N/A
11/30/2016	21	5	N/A	8	N/A
8/31/2016	20	5	N/A	5	N/A
5/31/2016	20	5	N/A	6	N/A
2/29/2016	20	5	N/A	6	N/A
11/30/2015	19	4	N/A	7	N/A
8/31/2015	18	4	N/A	7	N/A
5/31/2015	17	4	N/A	6	N/A
2/28/2015	14	3	N/A	5	N/A
11/30/2014	13	3	N/A	4	N/A
8/31/2014	11	3	N/A	5	N/A
5/31/2014	11	3	N/A	4	N/A
2/28/2014	10	3	N/A	4	N/A
11/30/2013	10	3	N/A	4	N/A
8/31/2013	10	3	N/A	3	N/A
5/31/2013	10	3	N/A	2	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: SLP's forecast earnings growth (29.5% per year) is above the savings rate (2.4%).

Earnings vs Market: SLP's earnings (29.5% per year) are forecast to grow faster than the US market (14.5% per year).

High Growth Earnings: SLP's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: SLP's revenue (13.8% per year) is forecast to grow faster than the US market (8.3% per year).

High Growth Revenue: SLP's revenue (13.8% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if SLP's Return on Equity is forecast to be high in 3 years time

Simulations Plus Future Growth

Future criteria checks 4/6

Key information

Recent future growth updates

Simulations Plus, Inc. Reiterates Earnings Guidance for the Fiscal Year 2024

Price target decreased by 9.1% to US$53.33

Price target decreased by 12% to US$55.00

Price target decreased to US$59.75

Price target increased to US$65.25

Simulations Plus, Inc. Provides Revenue Guidance for the Year 2022

Recent updates

lead Independent Director notifies of intention to sell stock

Upcoming dividend of US$0.06 per share

Second quarter dividend of US$0.06 announced

Second quarter 2024 earnings: EPS and revenues exceed analyst expectations

Now 43% overvalued after recent price rise

Simulations Plus, Inc. Declares a Cash Dividend, Payable on May 6, 2024

Why We're Not Concerned About Simulations Plus, Inc.'s (NASDAQ:SLP) Share Price

Simulations Plus, Inc. to Report Q2, 2024 Results on Apr 03, 2024

Capital Allocation Trends At Simulations Plus (NASDAQ:SLP) Aren't Ideal

Now 22% overvalued after recent price rise

Simulations Plus: Questionable Whether It Will Benefit Or Be Hurt By Generative AI

Simulations Plus, Inc. Releases GastroPlus Version 9.9

Upcoming dividend of US$0.06 per share at 0.6% yield

We Like Simulations Plus' (NASDAQ:SLP) Earnings For More Than Just Statutory Profit

First quarter 2024 earnings: EPS in line with analyst expectations despite revenue beat

President of PBPK notifies of intention to sell stock

Simulations Plus, Inc., Annual General Meeting, Feb 08, 2024

Simulations Plus, Inc. to Report Q1, 2024 Results on Jan 03, 2024

Simulations Plus, Inc. Reiterates Earnings Guidance for the Fiscal Year 2024

Capital Allocation Trends At Simulations Plus (NASDAQ:SLP) Aren't Ideal

Price target decreased by 9.1% to US$53.33

Simulations Plus, Inc. Declares Cash Dividend , Payable on November 6, 2023

Simulations Plus, Inc. to Report Q4, 2023 Results on Oct 25, 2023

Simulations Plus Receives New FDA Grant Award

Estimating The Intrinsic Value Of Simulations Plus, Inc. (NASDAQ:SLP)

Upcoming dividend of US$0.06 per share at 0.5% yield

Simulations Plus, Inc. Releases ADMET Predictor® 11

Third quarter 2023 earnings: Revenues and EPS in line with analyst expectations

Simulations Plus, Inc. Declares Cash Dividend , Payable on August 7, 2023

Co-Founder & Chairman notifies of intention to sell stock

Here's What's Concerning About Simulations Plus' (NASDAQ:SLP) Returns On Capital

Simulations Plus, Inc. to Report Q3, 2023 Results on Jul 06, 2023

Simulations Plus, Inc. (NasdaqGS:SLP) acquired Immunetrics, Inc. from LaunchCyte LLC for $23.5 million.

Price target decreased by 12% to US$55.00

Upcoming dividend of US$0.06 per share at 0.5% yield

Second quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

President exercised options to buy US$1.5m worth of stock.

President notifies of intention to sell stock

Simulations Plus Releases Redesigned NAFLDsym QSP Software Tool

Some Investors May Be Worried About Simulations Plus' (NASDAQ:SLP) Returns On Capital

Upcoming dividend of US$0.06 per share

Simulations Plus Releases DILIsym X (DSX) Beta with Redesigned Software Infrastructure

First quarter 2023 earnings: EPS and revenues miss analyst expectations

Simulations Plus, Inc. (NasdaqGS:SLP) announces an Equity Buyback for $50 million worth of its shares.

Co-Founder & Chairman notifies of intention to sell stock

Simulations Plus, Inc., Annual General Meeting, Feb 09, 2023

Price target decreased to US$59.75

Simulations Plus, Inc. to Report Q1, 2023 Results on Jan 04, 2023

With EPS Growth And More, Simulations Plus (NASDAQ:SLP) Makes An Interesting Case

High number of new and inexperienced directors

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Simulations Plus, Inc. Announces Board Changes

Simulations Plus, Inc. Declares Cash Dividend, Payable on November 7, 2022

A Look At The Intrinsic Value Of Simulations Plus, Inc. (NASDAQ:SLP)

Co-Founder & Chairman exercised options to buy US$1.5m worth of stock.

Simulations Plus Releases GastroPlus® Version 9.8.3

Simulations Plus, Inc. to Report Q4, 2022 Results on Oct 26, 2022

Here's What's Concerning About Simulations Plus' (NASDAQ:SLP) Returns On Capital

Simulations Plus Releases State-Of-The-Art QSP Software for Interstitial Lung Disease

Price target increased to US$65.25

Simulations Plus goes ex-dividend tomorrow

Upcoming dividend of US$0.06 per share

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

Simulations Plus, Inc. Declares Quarterly Cash Dividend, Payable on August 1, 2022

Simulations Plus Q3 2022 Earnings Preview

Simulations Plus, Inc. to Report Q3, 2022 Results on Jul 06, 2022

Simulations Plus (NASDAQ:SLP) Might Be Having Difficulty Using Its Capital Effectively

Simulations Plus Releases ADMET Predictor Version 10.4 (X.4)

Simulations Plus, Inc Announces U.S. FDA Renews Annual DILIsym Software Licenses for 2022